Riemser Arzneimittel AG Sells Veterinary Business to Ecuphar N.V.

08-Mar-2011 - Germany

Riemser Arzneimittel AG and Belgian company Ecuphar N.V. have announced that they have agreed on the sale of a large part of the veterinary business of Riemser to Ecuphar. The sale should take place during the first quarter of 2011.

As part of its further strategic development as a specialty pharmaceutical supplier, Riemser Arzneimittel AG will be selling a large part of both its veterinary product portfolio and its marketing and sales unit, to Ecuphar. The research and development and production divisions, as well as the Riemser swine flu will remain at Riemser. This acquisition will grant the Belgian company Ecuphar, which is specialised in veterinary medicine, direct access to the German veterinary market, an important factor in its European expansion strategy. In the future, Ecuphar will operate in Germany under the name of Ecuphar GmbH. The Company will be located in Greifswald.

"With Ecuphar, we are pleased to have found a partner who will continue and successfully expand the veterinary business we have built up. Riemser will thus be able to focus even more intensely on further growth in the area of human specialty pharmaceuticals", explains Dr. Michael Mehler, Chairman of the board of Riemser.

"The acquisition of the veterinary portfolio from Riemser, together with the experienced marketing and sales team is a stroke of luck for us, as it will allow us to gain quick, direct access to the German market. The acquired products will also complement our existing portfolio, with the result that we expect our position in the German market to be reinforced", comments Chris Cardon, CEO of Ecuphar N.V..

Both companies will also continue to cooperate following the sale. Ecuphar will continue to receive the products manufactured by Riemser in Greifswald and Leipzig exclusively from Riemser. "The production agreement is a job security measure for our locations and as such a significant part of the selling process", adds Dr. Mehler.

https://www.bionity.com/en/news/131208/riemser-arzneimittel-ag-sells-veterinary-business-to-ecuphar-n-v.html